In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model (Q80973413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Sylvie Pasco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Laurent Ramont

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lydie Venteo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michel Pluot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

François-Xavier Maquart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jean-Claude Monboisse

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

251-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

New functions for the matrix metalloproteinases in cancer progression

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Matrix metalloproteinases in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

The plasminogen activation system in tumor growth, invasion, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Basement membranes: structure, assembly and role in tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

New functional roles for non-collagenous domains of basement membrane collagens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.036

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2004.07.036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15530861%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference